

Syntactx, Now Part of NAMSA Information
Summary
Syntactx, Now Part of NAMSA is a private company that has been in the industry for 15 years. The company currently specializes in the Research, Biotechnology, Medical Research & Laboratories areas. The position of the President & CEO is occupied by Kenneth Ouriel. Its headquarters is located at New York, New York, USA. The number of employees ranges from 25 to 100. The annual revenue of Syntactx, Now Part of NAMSA varies between 5.0M and 25M. Total funding of the company - $1M. To connect with Syntactx, Now Part of NAMSA employee register on SignalHire.
Industries
Research
Headquarters Location
Employees Size
100-200 employees
Specialties
Medical Writing, Site Monitoring, Electronic Data Capture, SAS Programming, Safety, CEC and DSMB Oversight, Data Analysis and Statistics, Site Selection, Contracting, and Management, Pharmaceuticals, BIMO Audit, Clinical Evaluation Reports, Imaging Core Laboratory, FDA Panel Prep, Medical and Combination Devices, Regulatory Submissions, PMA Submissions, Trial Design, Global Regulatory Strategy, Post Market Studies, Investigator-Initiated Research
DMA Code
New York Metropolitan Area
Founded
2010
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Acquired
Contact Syntactx, Now Part of NAMSA
Organization Website
Social Links
Phone Number
+1 212 228 9000
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
1991 | Privately Held | 25 - 100 | 9.5M | $150K | |
2000 | Privately Held | 100 - 250 | 22.5M | $2M | |
2000 | Privately Held | 250 - 500 | 15M | $0 | |
1998 | Privately Held | 25 - 100 | 12M | $0 | |
- | Privately Held | 25 - 100 | 11.7M | $0 | |
2006 | - | 200-500 | - | $- |